Pushpamali De Silva Dienst : Laboratorium moleculaire immunologie (MIU) Pushpamali.DeSilva [at] bordet.be Publicaties Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review. Auteurs : Pellegrino B, Musolino A, Llop-Guevara A, Serra V, De Silva P, Hlavata Z, Sangiolo D, Willard-Gallo K, Solinas C Jaar : 2020 Journal : Transl Oncol Targeting CTLA-4 in cancer: Is it the ideal companion for PD-1 blockade immunotherapy combinations? Auteurs : De Silva P, Aiello M, Gu-Trantien C, Migliori E, Willard-Gallo K, Solinas C Jaar : 2020 Journal : Int J Cancer Significance of TIM3 expression in cancer: From biology to the clinic. Auteurs : Solinas C, De Silva P, Bron D, Willard-Gallo K, Sangiolo D Jaar : 2019 Journal : Semin Oncol LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer. Auteurs : Solinas C, Migliori E, De Silva P, Willard-Gallo K Jaar : 2019 Journal : Cancers (Basel) Targeting PD-1 in cancer: Biological insights with a focus on breast cancer. Auteurs : Solinas C, Aiello M, De Silva P, Gu-Trantien C, Migliori E, Willard-Gallo K Jaar : 2019 Journal : Crit Rev Oncol Hematol Meer publicaties »